Bausch Health Companies Inc (BHC)

$8.21 0.02 (0.24%)

19:00 EDT BHC Stock Quote Delayed 30 Minutes

7 Retirement Stocks to Buy Now OR You’ll Be Kicking Yourself Later

By Joel Baglole, InvestorPlace Contributor Jan 24, 2023

Consider adding these leading companies to a portfolio that is aimed at getting you to the finish line when it comes to retiring.

Why Is Bausch Health (BHC) Up 17% Today?

7 Stock Price Predictions That Are Actually Worth Listening To

BHC Stock Continues to Fall as Bausch Health Responds to Court Decision

Volume:

Previous Close -

Market Cap 2.95B

PE Ratio -14.16

EPS -0.58

Volume (Avg. Vol.) 2.58M

Day's Range $7.99 - $8.25

52-Week Range $4.00 - $10.23

Dividend & Yield N/A (N/A)

BHC Stock Predictions, Articles, and Bausch Health Companies Inc News

From InvestorPlace
From the Web

Bausch Health (BHC) Stock Plunges 50% on Patent News

By Josh Enomoto, InvestorPlace Contributor Jul 28, 2022

With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.

Billionaire Carl Icahn Is Betting Big on These 5 Stocks. Here’s Why.

By Eddie Pan, InvestorPlace Assistant News Writer Jun 1, 2022

Corporate raider Carl Icahn no longer manages money for external clients. However, he still manages more than $21 billion of 13F assets for his family....

Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO

By William White, InvestorPlace Writer May 10, 2022

Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.

BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today

By Chris MacDonald, InvestorPlace Contributor May 6, 2022

Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today.

BLCO Stock IPO: When Does Bausch + Lomb Go Public? What Is the Bausch + Lomb IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor May 2, 2022

Here's what investors may want to know about the upcoming BLCO stock IPO, as Bausch + Lomb is split off from its parent company this week.

BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health

By Eddie Pan, InvestorPlace Assistant News Writer Dec 20, 2021

The Mad Money host announced a new position in Bausch Health amid the spread of the omicron variant. Here's what you should know.

5 Healthcare Stocks for Good (Portfolio) Health

By Vince Martin, InvestorPlace Contributor Aug 3, 2020

These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

Bausch Health Earnings: BHC Stock Takes a Big 7% Hit on Mixed Q4

By William White, InvestorPlace Writer Feb 19, 2020

Bausch Health (BHC) earnings for the pharmaceutical company's fourth quarter of 2019 have BHC stock falling hard on Wednesday.

3 Big Stock Charts for Tuesday: Bausch Health, Booking Holdings, and Proofpoint

By Vince Martin, InvestorPlace Contributor Feb 11, 2020

Tuesday's big stock charts focus on 3 names facing near-term inflection points that should drive near-term direction.

4 Top Stock Trades for Tuesday: MCD, UAA, Berkshire

By Bret Kenwell, InvestorPlace Contributor Nov 4, 2019

Berkshire Hathaway, McDonald's, Under Armour and Bausch Health were our top stock trades from Monday. Here's a look at the charts.

10 Healthcare Stocks to Buy Despite the Headlines

By James Brumley, InvestorPlace Feature Writer Sep 10, 2019

Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.

Stock Market Today: How Many Times Will the Fed Cut Rates?

By Bret Kenwell, InvestorPlace Contributor Aug 6, 2019

After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.

10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019

By Vince Martin, InvestorPlace Contributor Jun 13, 2019

Wall Street analysts see significant upside in these 10 stocks to buy. And all ten have other reasons for optimism as well.

9 U.S. Stocks That Are Coming to Life Again

By James Brumley, InvestorPlace Feature Writer Feb 12, 2019

All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.

All Signals Are Positive for Buying Abbott Laboratories

By Chris Lau, InvestorPlace Contributor Jan 22, 2019

Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.

Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow

By Chris Lau, InvestorPlace Contributor Nov 8, 2018

Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

16 Stocks to Buy Before They Turn It Around

By Vince Martin, InvestorPlace Contributor Oct 11, 2018

GE stock is just one of the many turnaround stocks in the market. These 16 equities all could be stocks to buy - if execution improves.

5 Hot Stocks Today (That Could Crash Tomorrow)

By Bret Kenwell, InvestorPlace Contributor Jul 19, 2018

There are always hot stocks in the market but that doesn't mean investors should always buy -- they could be bull traps in the making.

Zoetis Declares New Dividend, Hinting At Undervaluation

From MarketBeat May 18, 2023

Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally

Why Shares of Bausch Health Soared Wednesday

From The Motley Fool May 17, 2023

The company won a big patent fight with a generic-drug maker.

Bausch Health soars amid court ruling in patent dispute with Norwich Pharma (NYSE:BHC)

From Seeking Alpha May 17, 2023

Bausch Health (BHC) soared 40% after a court ruling related to the company's patent suit vs Norwich Pharma over Xifaxan.A U.S

Bausch Health soars after court ruling in patent dispute with Norwich Pharma (NYSE:BHC)

From Seeking Alpha May 17, 2023

Bausch Health (BHC) soared 40% after a court ruling related to the company's patent suit vs Norwich Pharma over Xifaxan.A U.S

Bausch Health stock falls as Q1 net loss widens amid revenue miss

From Seeking Alpha May 4, 2023

Bausch Health Companies (BHC) stock fell ~17% on Thursday after Q1 results missed estimates. Read more here

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Nuvation Bio (NUVB)

From TipRanks Nov 8, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bausch Health Companies (

Bausch Health Companies Inc (BHC)

7 Retirement Stocks to Buy Now OR You’ll Be Kicking Yourself Later

Why Is Bausch Health (BHC) Up 17% Today?

7 Stock Price Predictions That Are Actually Worth Listening To

BHC Stock Continues to Fall as Bausch Health Responds to Court Decision

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Bausch Health Companies Inc (BHC)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BHC Stock Predictions, Articles, and Bausch Health Companies Inc News

Subscriber Sign in